CD4 and tuberculosis: Furthermore, in the current era, the introduction of integrase strand transfer inhibitor (INSTI)-based ART regimens, known for their rapid recovery of CD4 + T-cell counts and VL reduction, raises questions regarding the potential increase in the incidence of paradoxical TB-IRIS.